Clearing is a pioneering D2C healthcare platform dedicated to providing opioid-free care for chronic pain sufferers in the United States. Since its founding in 2020, the company has positioned itself at the forefront of digital health by collaborating with esteemed medical institutions such as Harvard, Johns Hopkins, and the Hospital for Special Surgery.
The startup is backed by an impressive roster of investors, including Bessemer Venture Partners, Founders Fund, and Breyer Capital. It has attracted notable entrepreneurs, including founders from companies like Hims, Seamless Grubhub, and Flatiron Health, which underscores strong industry confidence in Clearing’s vision and potential.
Clearing secured a $20.00M Seed Round investment on May 25, 2021, with contributions from Goodwater Capital, Torch Capital, and Threshold Ventures, among others. Focused on a significant market of over 50M chronic pain patients, Clearing is poised to make a substantial impact in the digital health and wellness industry.